While one report proposed that RIPK3 expression is suppressed in cancer cells by promoter methylation [27], it is more likely that in solid tumors RIPK3 expression is inhibited by hypoxia, which has been implicated in promoting cell survival and angiogenesis during tumor progression [44]. This evidence concerns the gene RIPK3 and neoplasm.